Pharmaceutically Active Microbial AhR Agonists as Innovative Biodrugs in Inflammation
Alterations of the microbiome occur in inflammatory and autoimmune diseases, a finding consistent with the role of the microbiome in the maintenance of the immune system homeostasis. In this regard, L-tryptophan (Trp) metabolites, of both host and microbial origin, act as important regulators of hos...
Saved in:
Main Authors: | Matteo Puccetti (Author), Marilena Pariano (Author), Claudio Costantini (Author), Stefano Giovagnoli (Author), Maurizio Ricci (Author) |
---|---|
Format: | Book |
Published: |
MDPI AG,
2022-03-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Turning Microbial AhR Agonists into Therapeutic Agents via Drug Delivery Systems
by: Matteo Puccetti, et al.
Published: (2023) -
Tackling Immune Pathogenesis of COVID-19 through Molecular Pharmaceutics
by: Matteo Puccetti, et al.
Published: (2021) -
Biologics, theranostics, and personalized medicine in drug delivery systems
by: Matteo Puccetti, et al.
Published: (2024) -
Strategies and delivery systems for cell-based therapy in autoimmunity
by: Matteo Puccetti, et al.
Published: (2024) -
Postbiotic-Enabled Targeting of the Host-Microbiota-Pathogen Interface: Hints of Antibiotic Decline?
by: Matteo Puccetti, et al.
Published: (2020)